Partner Headlines - BIIB

  1. John Paulson Bulks Up Health Care Bet

    GuruFocus
  2. Gilead, Johnson & Johnson or Roche?

    GuruFocus
  3. Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist ...

    GuruFocus
  4. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  5. Former Leaders Show Up On New Low List; D.R. Horton Sinks Again

    IBD
  6. Nike To Facebook: Frank Caruso Projects Long-Term Earnings Growth

    IBD
  7. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD
  8. Maybe Some Good News For A Big Biotech ETF

    Benzinga
  9. Sobi to present new interim ASPIRE data at EAHAD congress suggesting ...

    Benzinga
  10. Earnings Recap For January 27

    Benzinga
  11. Apple and Boeing Earnings, Plus Oil Drag, Combine to Dent Stocks

    Benzinga
  12. Biogen's Stock Pops Following Better-Than-Expected Q4 Results

    Benzinga
  13. 10 Stocks Moving In Wednesday's Pre-Market Session

    Benzinga
  14. Earnings Scheduled For January 27, 2016

    Benzinga
  15. Big Earnings Expectations For Big Biotech

    Benzinga
  16. Biogen Ticks Up Following EU Marketing Authorization Of Benepali

    Benzinga
  17. Biogen, Samsung JV Announces Etanercept Biosimilar Referencing ...

    Benzinga
  18. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD
  19. This Week Is Paramount For Biotech Stocks

    Benzinga
  20. Richard Snow Makes Huge Increases in Big-Name Stocks

    GuruFocus
  21. Jean Hynes Finds Her Pot of Gold

    GuruFocus
  22. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga
  23. Not All Of Clinton's Policies Are Bad For Pharmaceuticals

    Benzinga
  24. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD
  25. Early Global News: Virtual Reality Market Getting Really Big, ...

    Benzinga
  26. Sanofi chips at Biogen share

    IBD
  27. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  28. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  29. Sobi and Biogen's Elocta Approved by EC for Treatment of Haemophilia ...

    Benzinga
  30. Stocks Quietly Higher; JD.com Clears Key Resistance

    IBD
  31. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  32. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus
  33. Biogen Among Murray Stahl's Holdings With Growing Earnings

    GuruFocus
  34. 10 S&P 500 Companies With Green Operations

    Benzinga
  35. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  36. Biogen's Breach Of 50-Day Line Was Clear Sell Signal

    IBD
  37. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus
  38. Biotechs Among Stocks That Insiders Have Been Buying Lately

    Benzinga
  39. Biogen Is a Bargain

    GuruFocus
  40. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  41. Apple Upgraded To Buy; Amazon, McDonald's PTs Hiked

    IBD
  42. Hurricane Hillary Shifts Left, Slamming More Stocks

    IBD
  43. Biogen tops Q3, will cut jobs

    IBD
  44. Biogen Volatile After Q3 Beat, Raised Guidance And Disappointing ...

    Benzinga
  45. Why Biogen Stock Is Having A Huge Day

    Benzinga
  46. Biogen Beats Q3 Views, Cuts Workforce, Lifts Guidance

    IBD
  47. Early Gains Fizzle, Turn Mixed; Biogen, Ferrari Rise

    IBD
  48. Benzinga's Top #PreMarket Gainers

    Benzinga
  49. Earnings Scheduled For October 21, 2015

    Benzinga
  50. Fast Money Picks For October 20

    Benzinga
  51. Stock Week Ahead: Housing Data, Broad-Based Earnings Line Up

    Benzinga
  52. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD
  53. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  54. Valeant Subpoenaed By Federal Prosecutors On Pricing

    IBD
  55. Market Has Overreacted in Biogen

    GuruFocus
  56. Frank Sands' Undervalued Holdings With Growing EPS

    GuruFocus
  57. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD
  58. Stocks Inch Up; Oil Gains Ease; Alcoa, Tesla, Gap Stumble

    IBD
  59. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD
  60. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD
  61. Will Fund Managers Pump Up Edwards To New Breakout?

    IBD
  62. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  63. Trans Pacific Trade Pact Finally Agreed

    Benzinga
  64. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  65. Fast Money Traders Share The Stocks They Would Buy In Fourth ...

    Benzinga
  66. Stocks Rally, Will Gains Hold? Biotechs Try Second Rebound

    IBD
  67. Stocks Mixed In Late Trade; Post Falls More

    IBD
  68. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness
  69. Roche Drug Scores A Hit Against Stubborn Form Of MS

    IBD
  70. Can Valeant Heal After Clinton Price-Gouging Tweet?

    IBD
  71. Can Valeant Heal After Clinton Price Gouging Tweet?

    IBD
  72. Biogen Approaches Support Levels In $290 Handle

    Benzinga
  73. Biotechs Are Getting Killed Because Of Hillary Clinton's Response ...

    Benzinga
  74. The Undervalued Stocks Among Richard Snow's Recent Buys

    GuruFocus
  75. Goldman Sachs' Stock Picks if Rates Rise

    FoxBusiness
  76. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  77. Biogen Licenses Mitsubishi Tanabe Pharma's MT-1303 for Autoimmune ...

    Benzinga
  78. Biogen: 'A Nice Little Trade' Or Heading To New Lows?

    Benzinga
  79. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    Benzinga
  80. The Other Bearish Biotech ETF Is Looking Groovy, Too

    Benzinga
  81. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders ...

    GuruFocus
  82. Using ETFs To Run Your Own Hedge Fund

    Benzinga
  83. Morning Market Gainers

    Benzinga
  84. Benzinga's Top #PreMarket Gainers

    Benzinga
  85. AGTC Release Confirms Strategic Collaboration With Biogen Effective ...

    Benzinga
  86. The Best Companies of the Pharmaceuticals Industry - August 2 ...

    GuruFocus
  87. Benzinga's Top Initiations

    Benzinga
  88. IBD's Big Cap 20 Stocks Offer Refuge In Choppy Market

    IBD
  89. Vanguard Health Care Fund Buys Two New Stakes in Second Quarter

    GuruFocus
  90. These Two Biotechs Boast Big EPS Growth Rates

    IBD
  91. What Company Will Be Fastest Growing Big-Cap Biotech?

    IBD
  92. Regeneron Tops 3 Med Stocks Moving Big On Earnings

    IBD
  93. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD
  94. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  95. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD
  96. Caution Continues In Options Market This Week

    Benzinga
  97. A Big Day For Biotech And It's Not Going So Well

    Benzinga
  98. Benzinga's Volume Movers

    Benzinga
  99. A Look Ahead: Biotech And Energy ETFs To Watch This Week

    Benzinga
  100. Benzinga's Top Downgrades

    Benzinga
Trading Center